BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 16382466)

  • 21. Current role of liver transplantation for the treatment of urea cycle disorders: a review of the worldwide English literature and 13 cases at Kyoto University.
    Morioka D; Kasahara M; Takada Y; Shirouzu Y; Taira K; Sakamoto S; Uryuhara K; Egawa H; Shimada H; Tanaka K
    Liver Transpl; 2005 Nov; 11(11):1332-42. PubMed ID: 16237708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation.
    Sieders E; Hepkema BG; Peeters PM; TenVergert EM; de Jong KP; Porte RJ; Bijleveld CM; van den Berg AP; Lems SP; Gouw AS; Slooff MJ
    Liver Transpl; 2005 Dec; 11(12):1541-9. PubMed ID: 16315307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Donor-dominant one-way matching of human leukocyte antigen-A/B/DR alleles predicts graft-versus-host disease following living donor liver transplantation.
    Hirata M; Yagi S; Shindo T; Yoshizawa A; Kiguchi G; Kaneshiro M; Yurugi K; Miyachi Y; Iwamura S; Yao S; Uemoto S
    Hepatol Res; 2021 Jan; 51(1):135-148. PubMed ID: 33034106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility.
    Castillo-Rama M; Castro MJ; Bernardo I; Meneu-Diaz JC; Elola-Olaso AM; Calleja-Antolin SM; Romo E; Morales P; Moreno E; Paz-Artal E
    Liver Transpl; 2008 Apr; 14(4):554-62. PubMed ID: 18383092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Partial HLA matching and RH incompatibility resulting in graft versus host reaction and Evans syndrome after liver transplantation.
    Grosskreutz C; Gudzowaty O; Shi P; Rodriguez-Laiz G; Malone A; Isola L
    Am J Hematol; 2008 Jul; 83(7):599-601. PubMed ID: 18470884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of donor/recipient HLA-matching on outcome and recurrence of hepatitis C after liver transplantation.
    Langrehr JM; Puhl G; Bahra M; Schmeding M; Spinelli A; Berg T; Schönemann C; Krenn V; Neuhaus P; Neumann UP
    Liver Transpl; 2006 Apr; 12(4):644-51. PubMed ID: 16555324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fatal graft-versus-host disease after living-donor liver transplantation from an HLA-DR-mismatched donor.
    Shimata K; Sakamoto R; Anan T; Uchida K; Honda M; Kouroki M; Urabe T; Hayashida S; Yamamoto H; Sugawara Y; Inomata Y
    Pediatr Transplant; 2017 Nov; 21(7):. PubMed ID: 28834141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival.
    Loiseau P; Busson M; Balere ML; Dormoy A; Bignon JD; Gagne K; Gebuhrer L; Dubois V; Jollet I; Bois M; Perrier P; Masson D; Moine A; Absi L; Reviron D; Lepage V; Tamouza R; Toubert A; Marry E; Chir Z; Jouet JP; Blaise D; Charron D; Raffoux C
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):965-74. PubMed ID: 17640601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of graft prognosis in penetrating normal-risk keratoplasty by HLA class I and II matching.
    Reinhard T; Böhringer D; Enczmann J; Kögler G; Mayweg S; Wernet P; Sundmacher R
    Eye (Lond); 2004 Mar; 18(3):269-77. PubMed ID: 15004576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
    Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K;
    Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutrophils and lymphoid chimerism after adult living-related liver transplantation from a homozygous donor.
    Hajeer AH; Issa S; Alaskar A; Abdullah K; Awad M; Tbakhi A; Alabdulkareem A
    Transplant Proc; 2005 Dec; 37(10):4386-8. PubMed ID: 16387127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.
    Hauzenberger D; Schaffer M; Ringdén O; Hassan Z; Omazic B; Mattsson J; Wikström AC; Remberger M
    Tissue Antigens; 2008 Dec; 72(6):549-58. PubMed ID: 19000143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
    Ayuk F; Diyachenko G; Zabelina T; Panse J; Wolschke C; Eiermann T; Binder T; Fehse B; Erttmann R; Kabisch H; Bacher U; Kröger N; Zander AR
    Exp Hematol; 2008 Aug; 36(8):1047-54. PubMed ID: 18456390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for acute rejection in pediatric living related liver transplantation: the impact of HLA matching.
    Sugawara Y; Mizuta K; Kawarasaki H; Takayama T; Imamura H; Makuuchi M
    Liver Transpl; 2001 Sep; 7(9):769-73. PubMed ID: 11552209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of acute cellular rejection between living donor liver transplantation and cadaveric liver transplantation].
    Fan S; Zhang Z
    Zhonghua Yi Xue Za Zhi; 2001 Sep; 81(18):1092-4. PubMed ID: 11766604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of HLA matching in renal transplantation: experience from one center.
    Leivestad T; Reisaeter AV; Brekke IB; Vartdal F; Thorsby E
    Rev Immunogenet; 1999; 1(3):343-50. PubMed ID: 11256425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does a positive lymphocyte cross-match contraindicate living-donor liver transplantation?
    Hori T; Uemoto S; Takada Y; Oike F; Ogura Y; Ogawa K; Miyagawa-Hayashino A; Yurugi K; Nguyen JH; Hori Y; Chen F; Egawa H
    Surgery; 2010 Jun; 147(6):840-4. PubMed ID: 20096431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
    Okumura H; Yamaguchi M; Kotani T; Sugimori N; Sugimori C; Ozaki J; Kondo Y; Yamazaki H; Chuhjo T; Takami A; Ueda M; Ohtake S; Nakao S
    Eur J Haematol; 2007 Feb; 78(2):157-60. PubMed ID: 17313562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Case for High Resolution Extended 6-Loci HLA Typing for Identifying Related Donors in the Indian Subcontinent.
    Agarwal RK; Kumari A; Sedai A; Parmar L; Dhanya R; Faulkner L
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1592-1596. PubMed ID: 28603069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.